Resolution of the Interdisciplinary Council of Experts devoted to the problem of diagnosis and treatment of vaginitis of various etiologies in real clinical practice. Use of a new combined topical drug for the treatment of vaginitis of various etiologies. Educational project "ORIGINAL"


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Full Text

Restricted Access

About the authors

- -

References

  1. Анкирская А. С., Муравьева В.В. Интегральная оценка состояния микробиоты влагалища. Диагностика оппортунистических вагинитов. Акушерство и гинекология. 2020; 8 (1): 69-76. [Ankirskaya A.S., Muravyova V.V. Integral assessment of the state of the vaginal microbiota. Diagnosis of opportunistic vaginitis. Obstetrics and gynecology. 2020; 8 (1): 69-76. (in Russian)].
  2. Schwiertz A. (Ed). Microbiota of the Human Body. Advances in Experimental Medicine and Biology. 2016; 902: 83-93. http://link.springer.com/book/ 10.1007%2F978-3-319-31248-4
  3. Кира Е.Ф. Комбинированная терапия инфекционных заболеваний женских половых органов. Гинекология. 2010; 1: 12-5. [Kira E.F. Combined therapy of infectious diseases of female genital organs. Gynecology. 2010; 1: 12-5. (in Russian)].
  4. European (IUSTI/WHO) Guideline on the Management of Vaginal Discharge.
  5. Sobel J.D., Subramanian C., Foxman B., Fairfax M., Gygax S.E. Mixed vaginitis-more than coinfection and with therapeutic implications. Curr Infect Dis Rep. 2013 Apr; 15(2): 104-8.
  6. Олина А.А. Неспецифические инфекционные заболевания влагалища (медико-социальные, этиологические, клинико-диагностические особенности): Дис.. канд. мед. наук. Пермь; 2009; 24.
  7. Gajdacs M. The Concept of an Ideal Antibiotic: Implications for Drug Design. Molecules. 2019; 24(5): 892. Published 2019 Mar 3. https://doi.org/10.3390/ molecules24050892
  8. Ertabaklar H., Yaman Karadam S., Malatyali E., Ertug S. Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis. Mikrobiyol Bul. 2016 Oct; 50(4): 552-8.
  9. Pankuch G.A., Jacobs M.R., Appelbaum P.C. Susceptibilities of 428 gram-positive and negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin. Antimicrob. Agents Chemother. 1993 Aug;37(8):1649-54.
  10. Petrina M.A.B., Cosentino L.A., Rabe L.K., Hillier S.L. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. Anaerobe. 2017; 47: 115-9. https://doi.org/10.1016/j.anaerobe.2017.05.005
  11. Sood S. Chloramphenicol - A Potent Armament Against Multi-Drug Resistant (MDR) Gram Negative Bacilli? J. Clin Diagn Res. 2016; 10(2): DC01-DC3. https://doi.org/10.7860/JCDR/2016/14989.7167
  12. Czeizel A.E., Rockenbauer M., Sorensen H.T. et al. A population-based case-control teratologic study of oral chloramphenicol treatment during pregnancy. Eur J. Epidemiol. 2006; 16: 323-7. https://doi.org/10.1023/ A:1007623408010
  13. Thomseth V., Cejvanovic V., Jimenez-Solem E. et al. Exposure to topical chloramphenicol during pregnancy and the risk of congenital malformations: a Danish nationwide cohort study. Acta Ophthalmol. 2015 Nov; 93(7): 651-3. https://doi.org/10.1111/aos.12737
  14. Welscher Y.M., Jones L., van Leeuwen M.R. et al. Natamycin inhibits vacuole fusion at the priming phase via a specific interaction with ergosterol. Antimicrob Agents Chemother. 2010; 54(6): 2618-25. https://doi.org/10.1128/ AAC.01794-09
  15. WHO FOOD ADDITIVES SERIES: 48 http://www.inchem.org/documents/ jecfa/jecmono/v48je06.htm
  16. FDA: Federal Registry. 1980; 44: 37434-7.
  17. Uva L., Miguel D., Pinheiro C. et al. Mechanisms of action of topical corticosteroids in psoriasis. Int J. Endocrinol. 2012; 2012: 561018. https:// doi.org/10.1155/2012/561018
  18. Хамаганова И.В. Неспецифические вульвовагиниты. МС. 2011; 3-4. URL: https://cyberleninka.ru/article/n/nespetsificheskie-vulvovaginity (дата обращения: 12.03.2020)
  19. Обзор зарубежных клинических рекомендаций по лечению женщин с жалобами на выделения из влагалища (под редакцией В.Е. Радзинского). Акушерство и гинекология: новости, мнения, обучение. 2013; 1: 87.
  20. Nicolaides N.C., Pavlaki A.N., Maria Alexandra M.A. et al. Glucocorticoid Therapy and Adrenal Suppression. [Updated 2018 Oct 19]. In: Feingold K.R., Anawalt B., Boyce A., et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available from: https://www.ncbi.nlm.nih. gov/books/NBK279156
  21. Боровиков И.О., Куценко И.И., Рубинина Э.Р., Батмен С.К., Магай А.С. Преконцепционная подготовка пациенток со смешанным вагинальным дисбиозом. ФГБОУ ВО КубГМУ Минздрава России, Краснодар, Россия, 2019.
  22. Инструкция по медицинскому применению GATTEFOSSE [Instruction for medical use GATTEFOSSE]. https://www.gattefosse.com.
  23. Аполихина И.А., Саидова А.С., Куликов И.А., Баранов И.И. Применение нового комбинированного препарата для местного применения (Метронидазол+Хлорамфеникол+Натамицин+Гидрокортизона ацетат) для лечения вагинитов различной этиологии. Акушерство и гинекология. 2020; 5: 158-65.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies